Founding Year2024TractionConverge has completed over 40 programs with more than a dozen pharmaceutical and biotech customers, and has published public case studies demonstrating significant improvements in protein yield and antibody binding affinity.Organizations InvolvedMeta, OpenAI, WizFoundersDov GertzMarketPharmaceutical and biotech companiesLocationBoston, Massachusetts, United StatesCoinvestorsTLV Partners, Saras Capital, Vintage Investment Partners Company Description
Converge Bio is a startup that helps pharma and biotech companies develop drugs faster using generative AI trained on molecular data. The company trains generative models on DNA, RNA, and protein sequences, integrating them into research workflows to expedite drug development.